November 15, 2024

RFK Jr.'s Vision for U.S. Food and Drug System Reform

The FDA's nutrition department has to go: "They're not doing their job. They're not protecting our kids."

Reuters

November 15, 2024

RFK Jr to the FDA: 'Pack Your Bags'

"If you work for the FDA and are part of this corrupt system, I have two messages for you: 1. Preserve your records, and 2. Pack your bags."

Reuters

November 15, 2024

FDA Recall of Vessel Harvesters Adds to Shortage

FDA warns of serious injury risks with VasoView HemoPro 1.5, including silicone detachment leading to open surgery in some cases—17 injuries reported, 3 with unretrieved fragments.

Conexiant

November 07, 2024

Diabetes Affects 1 in 6 US Adults: CDC Data

In a stark reflection of diabetes screening gaps, more than one-quarter of U.S. adults with diabetes remained undiagnosed in 2021-2023, with obesity linked to a nearly four-fold higher prevalence compared to normal-weight individuals.

Conexiant

November 07, 2024

FDA Approves New Heart Device for AF

Varipulse is a pulsed field ablation system.

Reuters

November 01, 2024

Novo's Weight-Loss Drug Improves Liver Fibrosis in Late-Stage Trial

Novo Nordisk's latest trial reveals positive effects of weight-loss drug on liver health, pointing to potential benefits beyond weight management. #LiverHealth #Semaglutide

Reuters

October 30, 2024

FDA Approves Lowest Dose of Novo’s Weight-Loss Drug

The availability of Novo Nordisk's Wegovy and diabetes drug Ozempic has improved, with all doses now listed as available on the U.S. health regulator's website.

Reuters

April 29, 2024

Record Heat Waves Propel Surge in Heat-Related Illness

2023 brought record-breaking heat waves in the United States, significantly impacting vulnerable groups. Analysis by the CDC revealed a substantial number of heat-related illness (HRI) emergency department visits, resulting in multiple public health alerts.

Conexiant

November 17, 2023

FDA Approves Capivasertib With Fulvestrant for Breast Cancer

On November 16, 2023, the U.S. Food and Drug Administration (FDA) approved capivasertib (Truqap) with fulvestrant for adult patients with hormone receptor–positive, HER2-negative locally advanced or m...

The ASCO Post